Amalgamated Bank lessened its stake in shares of Chimera Investment Co. (NYSE:CIM – Free Report) by 66.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,652 shares of the real estate investment trust’s stock after selling 5,307 shares during the quarter. Amalgamated Bank’s holdings in Chimera Investment were worth $34,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of CIM. Cetera Advisors LLC acquired a new position in shares of Chimera Investment in the first quarter worth about $63,000. Symphony Financial Ltd. Co. acquired a new position in shares of Chimera Investment in the first quarter worth about $63,000. AlphaCentric Advisors LLC acquired a new position in shares of Chimera Investment in the second quarter worth about $179,000. Public Employees Retirement System of Ohio acquired a new position in shares of Chimera Investment in the first quarter worth about $72,000. Finally, Sound Income Strategies LLC acquired a new position in shares of Chimera Investment in the first quarter worth about $79,000. Institutional investors and hedge funds own 48.44% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently commented on CIM. Keefe, Bruyette & Woods boosted their price target on Chimera Investment from $15.00 to $16.00 and gave the stock a “market perform” rating in a research note on Thursday, August 8th. StockNews.com downgraded Chimera Investment from a “buy” rating to a “hold” rating in a report on Thursday, August 15th.
Chimera Investment Price Performance
Shares of NYSE:CIM opened at $15.53 on Wednesday. The company has a market cap of $1.25 billion, a PE ratio of 10.14 and a beta of 1.73. Chimera Investment Co. has a fifty-two week low of $11.28 and a fifty-two week high of $16.89. The firm has a 50-day simple moving average of $15.25 and a 200 day simple moving average of $13.98. The company has a quick ratio of 4.43, a current ratio of 4.43 and a debt-to-equity ratio of 3.75.
Chimera Investment (NYSE:CIM – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.03. Chimera Investment had a return on equity of 7.66% and a net margin of 28.79%. The business had revenue of $186.72 million for the quarter, compared to analysts’ expectations of $66.50 million. During the same period in the prior year, the firm earned $0.36 EPS. On average, sell-side analysts anticipate that Chimera Investment Co. will post 1.5 EPS for the current year.
Chimera Investment Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Monday, September 30th will be given a dividend of $0.37 per share. The ex-dividend date is Monday, September 30th. This represents a $1.48 annualized dividend and a dividend yield of 9.53%. This is a positive change from Chimera Investment’s previous quarterly dividend of $0.35. Chimera Investment’s dividend payout ratio is currently 96.73%.
Chimera Investment Company Profile
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Further Reading
- Five stocks we like better than Chimera Investment
- Stock Market Sectors: What Are They and How Many Are There?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Start Investing in Real Estate
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding CIM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chimera Investment Co. (NYSE:CIM – Free Report).
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.